Ascendis Pharma AS (ASND) — Capital Reinvestment Ratio
Latest as of December 2025:
0.05x
Ascendis Pharma AS (ASND) has a Capital Reinvestment Ratio of 0.05x as of December 2025, meaning it reinvests 0% of its operating cash flow ($70.67 Million) in capital expenditures ($3.30 Million). See cash generation quality of Ascendis Pharma AS to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.05x
Capex / Operating Cash Flow
Operating Cash Flow
$70.67 Million
USD
Capital Expenditures
$3.30 Million
USD
Data as of
Dec 2025
Most recent filing
Ascendis Pharma AS Capital Reinvestment Ratio (2013–2025)
This chart tracks Ascendis Pharma AS's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for Ascendis Pharma AS (2013–2025)
Year-by-year Capital Reinvestment Ratio for Ascendis Pharma AS from 2013 to 2025. For live market cap and broader valuation context, see Ascendis Pharma AS market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | $51.77 Million | $8.15 Million | ▼ -16.9% |
| 2013 | 0.19x | $6.31 Million | $1.20 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow